Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇩🇪DE · Life Sciences#1465K to 30K
- 🇹🇷TR · Life Sciences#873K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
2.4K to 12K🎙 Daily cadence·39 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
8K to 40K🇩🇪75%🇹🇷25% - Active Followers
Loyal subscribers who consistently listen
3.2K to 16K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 14 epsHosts
Recent guests
Recent episodes
Episode#117| Monica Wellejus:The Road to 3D-Printed Bone
Jun 21, 2026
43m 57s
Episode #115| Professor Paul Dalton: Inventing Melt Electrowriting and the Future of Biofabricationrication
Jun 4, 2026
59m 27s
Episode#116| Event Recording: Advancing 3D Surgical Planning
May 28, 2026
1h 58m 38s
Episode #114| Interview With Brigitte de Vet-Veithen, CEO of Materialise
May 11, 2026
41m 41s
Episode#113| How 3D Printing Explains the Unexplainable in Congenital Heart Disease with Dr. Tristan Ramcharan
May 10, 2026
16m 02s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/21/26 |  Episode#117| Monica Wellejus:The Road to 3D-Printed Bone | Ossiform is on track to bring the first 3D printed resorbable bone implant to the US market. The company’s preclinical data showed full bone regeneration in six months. Monica Wellejus, Chief Commercial Officer of Ossiform, joins The Lattice to explain how a company built to personalize bone implants for craniomaxillofacial surgeries is pivoting to mass-produced bone implants for foot deformity, and why hospital finance teams, not just the surgeons, may decide whether this technology actually... | 43m 57s | ||||||
| 6/4/26 |  Episode #115| Professor Paul Dalton: Inventing Melt Electrowriting and the Future of Biofabricationrication✨ | biofabricationmelt electrowriting+4 | Professor Paul Dalton | 3DHEALS | Perth, Australia | melt electrowritingbiofabrication+4 | — | 59m 27s | |
| 5/28/26 |  Episode#116| Event Recording: Advancing 3D Surgical Planning✨ | 3D surgical planningmedical technology+4 | — | — | — | surgery3D printing+5 | — | 1h 58m 38s | |
| 5/11/26 |  Episode #114| Interview With Brigitte de Vet-Veithen, CEO of Materialise✨ | 3D printingmedical technology+3 | Brigitte de Vet-Veithen | Materialise | — | MaterialiseBrigitte de Vet-Veithen+3 | — | 41m 41s | |
| 5/10/26 |  Episode#113| How 3D Printing Explains the Unexplainable in Congenital Heart Disease with Dr. Tristan Ramcharan✨ | 3D printingcongenital heart disease+4 | Dr. Tristan Ramcharan | MaterialiseEpisode#113 | Leuven Belgium | 3D printingcongenital heart disease+5 | — | 16m 02s | |
| 4/23/26 |  Episode# 112 | Automating Compounding Pharmacies: Prof. Alvaro Goyanes, FabRx✨ | 3D printingpharmaceuticals+3 | Prof Alvaro Goyanes | FabRx | London | 3D printed pharmaceuticalspersonalized medicine+3 | — | 15m 33s | |
| 4/10/26 |  Episode #111| Bench to Bedside: Bioprinting Innovation Virtual Event Recording✨ | bioprintingbiofabrication+3 | — | 3DHEALS | — | bioprintingbiofabrication+3 | — | 1h 48m 44s | |
| 4/10/26 |  Episode #110 | Neurotech Investing With Varun Turlapati, Chaanakya Capital✨ | neurotechnologyventure capital+3 | Varun Turlapati | Chaanakya Capital | — | neurotechinvesting+5 | — | 1h 02m 03s | |
| 3/29/26 |  Episode #109| March Newsletter: From Bioprinted Organs To FDA Cleared Implants In Healthcare 3D Printing✨ | healthcare 3D printingbioprinting+4 | — | bioprinted organsFDA cleared implants+8 | — | 3D printingbioprinted organs+5 | — | 11m 01s | |
| 3/14/26 |  Episode #108 | Teleporting Medicine with 3D Printing - Dr. Stephen Ryan, PolyUnity✨ | 3D printinghealthcare+4 | Dr. Stephen Ryan | PolyUnity3DHEALS | — | 3D printingmedical parts+5 | — | 55m 58s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 2/23/26 |  Episode#107 | The Lattice Feb 2026 - Latest News in Healthcare 3D Printing✨ | healthcare 3D printingemissions safety+4 | — | custom eyewearimplant surfaces+2 | space-based biomanufacturing | healthcare3D printing+5 | — | 6m 50s | |
| 2/22/26 |  Episode #106| Bionic Hands For Humans and Robots: The Psyonic Story✨ | bionic handssoft robotics+4 | — | Psyonic3DHEALS | — | bionic handssoft robotics+5 | — | 53m 51s | |
| 1/26/26 |  Episode #105 | Jan 2026 News: ARPA-H Organ "Moonshots", Point-of-Care Manufacturing, and More✨ | healthcare3D printing+4 | — | UT SouthwesternCarnegie Mellon+1 | — | 3D printingbioprinting+5 | — | 5m 13s | |
| 1/17/26 |  Episode #104| 3DHEALS2026 JP Morgan San Francisco (Live Recording) - Invest in 3D✨ | 3D printinghealthcare+4 | — | 3DHEALSEpisode #104| 3DHEALS2026 JP Morgan San Francisco (Live Recording) | San Francisco | 3D softwarehealthcare innovation+3 | — | 2h 09m 53s | |
| 12/28/25 |  Episode #103 | Design for Medical 3D Technology (Virtual Event)✨ | 3D printingmedical technology+4 | Matthew Shomper | Not a Robot Engineering | — | 3D printingCAD+3 | — | 1h 41m 50s | |
| 12/19/25 |  Episode #102 | Can Bioprinting Reshape The Future of Immunology? | We explore how to move IVIG from donor scarcity to on‑demand manufacturing with tissue‑engineered bioreactors, and why that shift could lower costs, expand access, and improve consistency. We dig into polyclonal advantages, regulatory guardrails, scaling plans, and what success would mean for complex biologics beyond antibodies. • Defining a bioreactor that recreates human tissue niches • Why polyclonal IVIG remains essential across 100+ conditions • Limits of donor‑dependent plasma supply a... | 41m 34s | ||||||
| 11/27/25 |  Episode #101 | Therapeutic Hardware: Can Implants Also Heal? With Alyssa Huffman Allumin8 | In this episode, Alyssa Huffman, CEO and co-founder of Allumin8, shares the six-year journey behind a first-of-its-kind 5.5 mm porous, 3D-printed pedicle screw. We discussed how Allumin8 earned FDA clearance and why design details matter for fatigue, fixation, and fewer revisions. We also map a path toward therapeutic hardware that integrates orthobiologics without slowing surgeons down. Critical questions addressed: Why does 5.5 mm matter so much? How does Gaussian topography support bone ... | 1h 08m 04s | ||||||
| 11/20/25 |  Episode #100 | 3D Printing and 3D Tech in Pediatric Cardiology (Live Recording) | Imagine holding a child’s heart in your hands and seeing the exact path a surgeon must take before a single incision. That shift from uncertainty to clarity frames this conversation on how 3D printing, virtual reality, and advanced imaging are transforming pediatric cardiology. Our speakers show how AI-assisted segmentation, multimodality fusion, VR rehearsal, and rapid mixed-reality planning are reshaping preoperative strategy and improving communication with families. Sarah Ptashnik of Mate... | 2h 01m 57s | ||||||
| 11/4/25 |  Episode #98 | Meeting the Bioprinting Vascular Challenge: VoxCell CEO Dr. Karolina Valente | In this episode, Dr. Karolina Valente, Founder and CEO of VoxCell BioInnovation, discusses her journey in biotechnology, focusing on 3D bioprinting and its impact on cancer research and drug discovery. She shares insights into her leadership at VoxCell, the company's growth, and the accolades it has received. Dr. Valente also talks about the importance of partnerships, the future of biotechnology, and her personal experiences that drive her passion for innovation. Questions answered: How di... | 1h 04m 36s | ||||||
| 11/1/25 |  Episode # 97 | Is ChatGPT Making Us Dumb? | Summary In this conversation, Jenny Chen explores the complex implications of ChatGPT on intelligence and education. She emphasizes the need for careful consideration of the technology's impact, particularly in academic settings, and discusses the broader context of a technological revolution that may have both positive and negative consequences. Takeaways Is ChatGPT making us dumb?This is a much more complicated question.ChatGPT is problematic, especially for students.We should consider... | 11m 47s | ||||||
| 10/30/25 |  Episode #96 | The Future of Surgical Digital Twin with Gilly Yildirim (CEO, Vent Creativity) | How well do we really understand the body? For decades, surgeons have relied on static scans and flat 2D models to plan procedures. Gilly Yildirim believes it’s time to expand our view to more dimensions. As founder and CEO of Vent Creativity, he is bringing together point clouds, digital twins, and physics-based AI to capture movement with a level of precision that static imaging is far from. In conversation with Jenny Chen, Gilly Yildirim describes how his team built a platform that sees t... | 1h 13m 44s | ||||||
| 9/26/25 |  Episode #95 | Microfluidics & Additive Innovation with Paul Marshall | Microfluidics has long promised to reshape diagnostics, drug discovery, and laboratory science. Microfluidics is about manipulating how tiny amounts of liquid move through channels no wider than a human hair; a "lab on a chip" diagnostic. Now imagine being able to 3D print those channels instead of painstakingly etching them. Paul Marshall, CEO of Rapid Fluidics, is working to improve the norm by applying additive manufacturing to the design and production of microfluidic systems. In this epi... | 1h 01m 08s | ||||||
| 9/12/25 |  Episode #93 | 3D Design & Geometric Intelligence with Elissa Ross | What happens when advanced mathematics meets manufacturing? The result is a new way of creating products that range from record-breaking running shoes to life-changing medical devices. In this episode, we sit down with Elissa Ross, mathematician and CEO of Metafold 3D, to explore how her company is using mathematics to reshape design and manufacturing. Metafold’s platform is built on geometric intelligence which is her company's novel approach that transforms shapes into data that can be anal... | 1h 02m 34s | ||||||
| 8/27/25 |  Episode #92 | Nanochon: Joint Repair Layer by Layer | Cartilage injuries sideline millions every year, yet current treatments often fail to restore long-term function. In this episode, Dr. Nathan Castro and Dr. Ben Holmes, co-founders of Nanochon, explain how they are tackling this challenge with a 3D-printed implant designed not only to replace damaged tissue but to help it regrow. What began as a collaboration in a graduate lab has grown into a company now preparing for its first human clinical trial. Their journey began at George Washington U... | 1h 09m 48s | ||||||
| 8/21/25 |  Episode #91 | 3D Printed Pharmaceuticals (Virtual Event Recording) | What if your medication could be made just for you? No more pill overload and no more awkward dosing workarounds. Just the exact treatment you need when you need it. That is the promise of 3D printed pharmaceuticals. Drug manufacturing has relied on a one-size-fits-all model for decades. Nearly half of all medications lack proper formulations for children and seniors are often left struggling to manage boxes of pills each day. It is time for a smarter, more personal approach. In this episode,... | 1h 45m 00s | ||||||
Showing 25 of 45
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.